The Vaccine Is Here. Now for the Hard Part.

Editor’s Note: The Atlantic is making vital coverage of the coronavirus available to all readers. Find the collection here.

In a historic moment during the darkest days of the COVID-19 pandemic, an FDA advisory committee voted today in favor of authorizing the first vaccine against COVID-19. The formal implementation of this recommendation, which would allow the vaccine to be given to anyone 16 or older, is expected to follow imminently.

This marks the beginning of a new and hopeful phase in a crisis that has killed nearly 300,000 Americans and caused widespread economic collapse. Having endured more deaths than any other country, the U.S. has manufactured of doses in anticipation of this moment. Vaccines should be available for some Americans next week, with doses going to health-care workers and older adults at the highest risk